Seeking Alpha
03 Jul 2026, 12:00 UTC · 2h ago
A Foot In The Future And The Past: Genpact Limited
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Seeking Alpha
03 Jul 2026, 12:00 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
3 claims · each scored for market impact
Genpact is estimated to be 53% undervalued with a fair value target of $60, trading at a forward P/E of 6.75 compared to a 10-year average of 17.1. — A significant valuation gap relative to historical norms typically triggers a strong corrective rally if recognized by the market.
+0.80The AI-led Advanced Technology Solutions (ATS) segment revenue surged by 24.3% in Q1 2026. — High growth in a high-margin, futuristic segment suggests a successful pivot to AI, increasing long-term growth expectations.
+0.60Genpact reported Q1 2026 revenue growth of 6.7% and EPS growth of 16.7%. — Strong bottom-line growth exceeding top-line growth indicates improved operational efficiency and profitability.
+0.40Which stocks this story touches
Continue reading
6 related stories
Top 1 mover · tap to explore
The company reported robust earnings growth, strong ATS segment revenue, and is currently considered significantly undervalued.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
24/7 Wall Street
1h ago
